U.S. News Highlights: From Fed Chief Nomination to Psychedelic Drug Surge
The U.S. domestic news includes Kevin Warsh's preparation for a Senate hearing on his Federal Reserve nomination, a surge in psychedelic drug developer shares due to faster FDA reviews ordered by Trump, and discussions surrounding energy policies amid tensions with Iran. Furthermore, controversies and official resignations make headlines.
In the U.S. domestic news cycle, Kevin Warsh faces a significant test as he prepares to present his views on monetary policy in a Senate hearing. The former Federal Reserve Governor's nomination for Fed chair has sparked debate, especially with Republicans demanding ongoing investigations to be dropped.
Meanwhile, psychedelic drug developers saw a significant rise in shares following President Trump's executive order to expedite FDA reviews and increase federal research funding, signaling a potential boom in the sector. Companies like AtaiBeckley and Compass Pathways experienced notable jumps in their stock prices.
As international tensions simmer, President Trump reassures Americans of lower gas prices post-Iran war, countering statements from his energy chief. Domestic political maneuvering continues with energy strategies and Justice Department investigations adding layers to the national discourse.
ALSO READ
-
Kevin Warsh Vows to Preserve Fed Independence Amid Challenges
-
Kevin Warsh's Vision for a Reform-Oriented Federal Reserve
-
Fed Nominee Warsh: Monetary Policy Showdown at Senate Hearing
-
Financial Markets Eye Stability Amid Iran Negotiations and Federal Reserve Oversight
-
Senate Scrutiny: Delaying Kevin Warsh's Fed Confirmation
Google News